Net Income (TTM) Chart

Historical Net Income (TTM) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 28.52M
March 31, 2026 -2.376M
December 31, 2025 -16.14M
September 30, 2025 -44.32M
June 30, 2025 -93.27M
March 31, 2025 -129.72M
December 31, 2024 -140.04M
September 30, 2024 -195.54M
June 30, 2024 -198.76M
March 31, 2024 -217.42M
December 31, 2023 -262.14M
September 30, 2023 -267.88M
June 30, 2023 -330.82M
March 31, 2023 -327.23M
December 31, 2022 -311.46M
Date Value
September 30, 2022 -310.76M
June 30, 2022 -260.04M
March 31, 2022 -234.64M
December 31, 2021 -206.36M
September 30, 2021 -169.08M
June 30, 2021 -150.30M
March 31, 2021 -143.71M
December 31, 2020 -135.68M
September 30, 2020 -114.20M
June 30, 2020 -90.47M
March 31, 2020 -63.35M
December 31, 2019 -42.00M
September 30, 2019 -35.03M
June 30, 2019 -28.22M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (TTM) Range, Past 5 Years

View Net Income (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (TTM) Benchmarks

View Net Income (TTM) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 380.48M
Insmed, Inc. -875.31M
Emergent BioSolutions, Inc. -176.80M
Exelixis, Inc. 860.62M
Puma Biotechnology, Inc. 26.72M